Miphic
Techstars '24Wilmington, US · Founded 2022 · 4 employees on LinkedIn · 1 known investors
Miphic provides imaging-based diagnostic screening of mitochondrial function to identify drug efficacy and personalized treatment options for cancer, neurodegenerative disease, diabetes, and aging-related conditions. The platform screens up to 96 conditions simultaneously to support drug discovery, personalized medicine selection, and metabolic research.
Founders & leadership
Miphic was founded in 2022 by Gena Nikitin.
GN
Gena NikitininFounder · CEOFounder of Miphic, which provides imaging-based diagnostic screening of mitochondrial function to support drug discovery and personalized medicine development across cancer, neurodegenerative disease, and metabolic conditions.
Investors · 1
Frequently asked questions
- What does Miphic do?
- Miphic provides imaging-based diagnostic screening of mitochondrial function to identify drug efficacy and personalized treatment options for cancer, neurodegenerative disease, diabetes, and aging-related conditions. The platform screens up to 96 conditions simultaneously to support drug discovery, personalized medicine selection, and metabolic research.
- Who founded Miphic?
- Miphic was founded by Gena Nikitin in 2022.
- Who are Miphic's investors?
- Miphic's investors include Techstars.
- Where is Miphic headquartered?
- Miphic is headquartered in Wilmington, US.